Aigen Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,018
Closed -$92K 893
2020
Q2
$92K Buy
+11,018
New +$92K 0.01% 763